In the past week, MIRA stock has gone down by -15.64%, with a monthly gain of 158.42% and a quarterly surge of 171.76%. The volatility ratio for the week is 9.28%, and the volatility levels for the last 30 days are 35.84% for Mira Pharmaceuticals Inc The simple moving average for the past 20 days is -25.20% for MIRA’s stock, with a 34.77% simple moving average for the past 200 days.
Is It Worth Investing in Mira Pharmaceuticals Inc (NASDAQ: MIRA) Right Now?
Company’s 36-month beta value is 4.38.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for MIRA is 9.52M, and currently, short sellers hold a 4.70% ratio of that floaft. The average trading volume of MIRA on August 20, 2024 was 5.01M shares.
MIRA) stock’s latest price update
Mira Pharmaceuticals Inc (NASDAQ: MIRA)’s stock price has gone decline by -7.77 in comparison to its previous close of 1.93, however, the company has experienced a -15.64% decrease in its stock price over the last five trading days. accesswire.com reported 2024-08-19 that MIAMI, FL / ACCESSWIRE / August 19, 2024 / MIRA Pharmaceuticals Inc. (NASDAQ:MIRA) “MIRA” or the “Company”), a leading pre-clinical-stage pharmaceutical company, is pleased to provide a comprehensive update on its recent achievements and scientific advancements as it nears a crucial milestone: the submission of its Investigational New Drug (IND) application by the end of the year. This update highlights the company’s strategic progress, significant scientific breakthroughs, and the expertise driving its innovative drug candidates toward clinical trials.
MIRA Trading at 30.47% from the 50-Day Moving Average
After a stumble in the market that brought MIRA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -73.96% of loss for the given period.
Volatility was left at 35.84%, however, over the last 30 days, the volatility rate increased by 9.28%, as shares sank -64.47% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +130.87% upper at present.
During the last 5 trading sessions, MIRA fell by -15.64%, which changed the moving average for the period of 200-days by -8.25% in comparison to the 20-day moving average, which settled at $2.2183. In addition, Mira Pharmaceuticals Inc saw 69.52% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MIRA starting from Aminov Erez, who purchase 8,700 shares at the price of $0.94 back on May 21 ’24. After this action, Aminov Erez now owns 382,200 shares of Mira Pharmaceuticals Inc, valued at $8,176 using the latest closing price.
McNulty Brian Patrick, the 10% Owner of Mira Pharmaceuticals Inc, sale 61,331 shares at $3.98 during a trade that took place back on Dec 04 ’23, which means that McNulty Brian Patrick is holding 723,062 shares at $244,097 based on the most recent closing price.
Stock Fundamentals for MIRA
The total capital return value is set at -4.38. Equity return is now at value -748.59, with -373.77 for asset returns.
Currently, EBITDA for the company is -8.53 million with net debt to EBITDA at 0.29. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.68.
Conclusion
In a nutshell, Mira Pharmaceuticals Inc (MIRA) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
